%0 Generic
%A Fasching, P. A.
%A Bardia, A.
%A Nusch, A.
%A Jerusalem, G.
%A Chan, A.
%A El Saghir, N.
%A Alba, E.
%A Im, S-A.
%A Janni, W.
%A Chandiwana, D.
%A Lanoue, B.
%A Thuerigen, A.
%A Gaur, A.
%A Harbeck, N.
%T Pooled analysis of patient (pt)-reported quality of life (QOL) in the MONALEESA (ML)-2,-3, and-7 trials of ribociclib (RIB) plus endocrine therapy (ET) to treat hormone receptore-positive, HER2-negative (HR+/HER2L) advanced breast cancer (ABC)
%D 2020
%@ 0923-7534
%U https://hdl.handle.net/10668/26855
%~